SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2gfg'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1A4G_A_ZMRA466_1
(NEURAMINIDASE)
2gfg BH2851
(Bacillus
halodurans)
5 / 12 ARG A 184
GLU A 149
GLU A 151
GLU A   6
GLU A   8
EDO  A 503 (-4.2A)
EDO  A 503 (-3.0A)
UNL  A 500 ( 2.8A)
UNL  A 500 ( 3.9A)
EDO  A 503 ( 3.9A)
1.42A 1a4gA-2gfgA:
undetectable
1a4gA-2gfgA:
19.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1A4G_B_ZMRB466_1
(NEURAMINIDASE)
2gfg BH2851
(Bacillus
halodurans)
5 / 12 ARG A 184
GLU A 149
GLU A 151
GLU A   6
GLU A   8
EDO  A 503 (-4.2A)
EDO  A 503 (-3.0A)
UNL  A 500 ( 2.8A)
UNL  A 500 ( 3.9A)
EDO  A 503 ( 3.9A)
1.41A 1a4gB-2gfgA:
undetectable
1a4gB-2gfgA:
19.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))
2gfg BH2851
(Bacillus
halodurans)
5 / 10 LEU A 168
ILE A 167
LEU A  25
LEU A  21
VAL A  13
None
1.12A 1cqpA-2gfgA:
undetectable
1cqpB-2gfgA:
undetectable
1cqpA-2gfgA:
21.74
1cqpB-2gfgA:
21.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1EQB_A_FFOA1293_2
(SERINE
HYDROXYMETHYLTRANSFE
RASE)
2gfg BH2851
(Bacillus
halodurans)
3 / 3 SER A 156
GLU A 157
GLU A 158
EDO  A 504 (-4.6A)
None
None
0.56A 1eqbD-2gfgA:
undetectable
1eqbD-2gfgA:
18.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1EQB_C_FFOC3293_0
(SERINE
HYDROXYMETHYLTRANSFE
RASE)
2gfg BH2851
(Bacillus
halodurans)
3 / 3 SER A 156
GLU A 157
GLU A 158
EDO  A 504 (-4.6A)
None
None
0.56A 1eqbB-2gfgA:
undetectable
1eqbB-2gfgA:
18.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2CML_A_ZMRA1477_1
(NEURAMINIDASE)
2gfg BH2851
(Bacillus
halodurans)
5 / 12 ARG A 184
GLU A 149
GLU A 151
GLU A   6
GLU A   8
EDO  A 503 (-4.2A)
EDO  A 503 (-3.0A)
UNL  A 500 ( 2.8A)
UNL  A 500 ( 3.9A)
EDO  A 503 ( 3.9A)
1.46A 2cmlA-2gfgA:
undetectable
2cmlA-2gfgA:
18.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2CML_C_ZMRC3477_1
(NEURAMINIDASE)
2gfg BH2851
(Bacillus
halodurans)
5 / 12 ARG A 184
GLU A 149
GLU A 151
GLU A   6
GLU A   8
EDO  A 503 (-4.2A)
EDO  A 503 (-3.0A)
UNL  A 500 ( 2.8A)
UNL  A 500 ( 3.9A)
EDO  A 503 ( 3.9A)
1.46A 2cmlC-2gfgA:
undetectable
2cmlC-2gfgA:
18.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2I91_A_ACTA601_0
(60 KDA SS-A/RO
RIBONUCLEOPROTEIN)
2gfg BH2851
(Bacillus
halodurans)
4 / 7 TYR A  39
SER A 140
SER A 122
THR A 123
None
1.06A 2i91A-2gfgA:
undetectable
2i91A-2gfgA:
17.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2I91_B_ACTB602_0
(60 KDA SS-A/RO
RIBONUCLEOPROTEIN)
2gfg BH2851
(Bacillus
halodurans)
4 / 7 TYR A  39
SER A 140
SER A 122
THR A 123
None
1.06A 2i91B-2gfgA:
undetectable
2i91B-2gfgA:
17.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2J2P_B_SC2B1290_1
(FICOLIN-2)
2gfg BH2851
(Bacillus
halodurans)
4 / 8 LEU A  67
LEU A 108
ASP A 107
ASP A 103
None
0.99A 2j2pA-2gfgA:
undetectable
2j2pB-2gfgA:
undetectable
2j2pA-2gfgA:
20.44
2j2pB-2gfgA:
20.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2OIP_E_MTXE621_1
(CHAIN A, CRYSTAL
STRUCTURE OF DHFR)
2gfg BH2851
(Bacillus
halodurans)
5 / 12 ALA A 126
LEU A 135
LEU A  25
SER A  23
ILE A 173
None
1.06A 2oipE-2gfgA:
undetectable
2oipE-2gfgA:
17.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QEL_B_QELB1_1
(NMDA GLUTAMATE
RECEPTOR SUBUNIT
GLUTAMATE [NMDA]
RECEPTOR SUBUNIT
EPSILON-2)
2gfg BH2851
(Bacillus
halodurans)
5 / 11 LEU A 135
ALA A 160
ILE A   7
THR A 170
GLU A 166
None
EDO  A 504 ( 4.3A)
None
None
None
1.36A 3qelA-2gfgA:
undetectable
3qelB-2gfgA:
undetectable
3qelA-2gfgA:
19.11
3qelB-2gfgA:
21.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SAN_A_ZMRA901_1
(NEURAMINIDASE)
2gfg BH2851
(Bacillus
halodurans)
5 / 12 ARG A 184
GLU A 149
GLU A 151
GLU A   6
GLU A   8
EDO  A 503 (-4.2A)
EDO  A 503 (-3.0A)
UNL  A 500 ( 2.8A)
UNL  A 500 ( 3.9A)
EDO  A 503 ( 3.9A)
1.47A 3sanA-2gfgA:
undetectable
3sanA-2gfgA:
17.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SAN_B_ZMRB901_1
(NEURAMINIDASE)
2gfg BH2851
(Bacillus
halodurans)
5 / 12 ARG A 184
GLU A 149
GLU A 151
GLU A   6
GLU A   8
EDO  A 503 (-4.2A)
EDO  A 503 (-3.0A)
UNL  A 500 ( 2.8A)
UNL  A 500 ( 3.9A)
EDO  A 503 ( 3.9A)
1.47A 3sanB-2gfgA:
undetectable
3sanB-2gfgA:
17.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TJ7_C_ACTC608_0
(GBAA_1210 PROTEIN)
2gfg BH2851
(Bacillus
halodurans)
5 / 5 GLU A   8
ARG A  57
LYS A  68
ARG A 125
GLU A 151
EDO  A 503 ( 3.9A)
UNL  A 500 ( 3.4A)
UNL  A 500 ( 3.7A)
UNL  A 500 (-3.6A)
UNL  A 500 ( 2.8A)
0.83A 3tj7C-2gfgA:
25.8
3tj7C-2gfgA:
45.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CPN_B_ZMRB700_1
(NEURAMINIDASE)
2gfg BH2851
(Bacillus
halodurans)
5 / 12 ARG A 184
GLU A 149
GLU A 151
GLU A   6
GLU A   8
EDO  A 503 (-4.2A)
EDO  A 503 (-3.0A)
UNL  A 500 ( 2.8A)
UNL  A 500 ( 3.9A)
EDO  A 503 ( 3.9A)
1.43A 4cpnB-2gfgA:
undetectable
4cpnB-2gfgA:
17.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CPZ_A_ZMRA1471_1
(NEURAMINIDASE)
2gfg BH2851
(Bacillus
halodurans)
5 / 12 ARG A 184
GLU A 149
GLU A 151
GLU A   6
GLU A   8
EDO  A 503 (-4.2A)
EDO  A 503 (-3.0A)
UNL  A 500 ( 2.8A)
UNL  A 500 ( 3.9A)
EDO  A 503 ( 3.9A)
1.44A 4cpzA-2gfgA:
undetectable
4cpzA-2gfgA:
17.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CPZ_B_ZMRB1471_1
(NEURAMINIDASE)
2gfg BH2851
(Bacillus
halodurans)
5 / 12 ARG A 184
GLU A 149
GLU A 151
GLU A   6
GLU A   8
EDO  A 503 (-4.2A)
EDO  A 503 (-3.0A)
UNL  A 500 ( 2.8A)
UNL  A 500 ( 3.9A)
EDO  A 503 ( 3.9A)
1.40A 4cpzB-2gfgA:
undetectable
4cpzB-2gfgA:
17.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CPZ_C_ZMRC1470_1
(NEURAMINIDASE)
2gfg BH2851
(Bacillus
halodurans)
5 / 12 ARG A 184
GLU A 149
GLU A 151
GLU A   6
GLU A   8
EDO  A 503 (-4.2A)
EDO  A 503 (-3.0A)
UNL  A 500 ( 2.8A)
UNL  A 500 ( 3.9A)
EDO  A 503 ( 3.9A)
1.38A 4cpzC-2gfgA:
undetectable
4cpzC-2gfgA:
17.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CPZ_D_ZMRD1471_1
(NEURAMINIDASE)
2gfg BH2851
(Bacillus
halodurans)
5 / 12 ARG A 184
GLU A 149
GLU A 151
GLU A   6
GLU A   8
EDO  A 503 (-4.2A)
EDO  A 503 (-3.0A)
UNL  A 500 ( 2.8A)
UNL  A 500 ( 3.9A)
EDO  A 503 ( 3.9A)
1.42A 4cpzD-2gfgA:
undetectable
4cpzD-2gfgA:
17.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CPZ_E_ZMRE1471_1
(NEURAMINIDASE)
2gfg BH2851
(Bacillus
halodurans)
5 / 12 ARG A 184
GLU A 149
GLU A 151
GLU A   6
GLU A   8
EDO  A 503 (-4.2A)
EDO  A 503 (-3.0A)
UNL  A 500 ( 2.8A)
UNL  A 500 ( 3.9A)
EDO  A 503 ( 3.9A)
1.43A 4cpzE-2gfgA:
undetectable
4cpzE-2gfgA:
17.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CPZ_G_ZMRG1471_1
(NEURAMINIDASE)
2gfg BH2851
(Bacillus
halodurans)
5 / 12 ARG A 184
GLU A 149
GLU A 151
GLU A   6
GLU A   8
EDO  A 503 (-4.2A)
EDO  A 503 (-3.0A)
UNL  A 500 ( 2.8A)
UNL  A 500 ( 3.9A)
EDO  A 503 ( 3.9A)
1.45A 4cpzG-2gfgA:
undetectable
4cpzG-2gfgA:
17.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HDL_A_DXCA75_0
(PPCA)
2gfg BH2851
(Bacillus
halodurans)
4 / 8 ILE A 128
ILE A 150
PHE A 152
GLY A 154
None
None
EDO  A 504 ( 4.9A)
EDO  A 504 (-3.2A)
0.95A 4hdlA-2gfgA:
undetectable
4hdlA-2gfgA:
16.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4I00_A_ZMRA509_1
(NEURAMINIDASE)
2gfg BH2851
(Bacillus
halodurans)
5 / 12 ARG A 184
GLU A 149
GLU A 151
GLU A   6
GLU A   8
EDO  A 503 (-4.2A)
EDO  A 503 (-3.0A)
UNL  A 500 ( 2.8A)
UNL  A 500 ( 3.9A)
EDO  A 503 ( 3.9A)
1.48A 4i00A-2gfgA:
undetectable
4i00A-2gfgA:
17.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4IJI_F_BEZF501_0
(GLUTATHIONE
S-TRANSFERASE-LIKE
PROTEIN YIBF)
2gfg BH2851
(Bacillus
halodurans)
4 / 8 SER A 122
ARG A  55
TYR A  39
ARG A  57
None
UNL  A 500 (-3.5A)
None
UNL  A 500 ( 3.4A)
1.05A 4ijiF-2gfgA:
undetectable
4ijiF-2gfgA:
22.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KR3_A_GLYA701_0
(GLYCINE--TRNA LIGASE)
2gfg BH2851
(Bacillus
halodurans)
4 / 6 GLU A 153
ARG A 125
GLU A   8
GLU A   6
UNL  A 500 ( 4.9A)
UNL  A 500 (-3.6A)
EDO  A 503 ( 3.9A)
UNL  A 500 ( 3.9A)
1.35A 4kr3A-2gfgA:
undetectable
4kr3A-2gfgA:
15.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LUH_A_ACTA610_0
(SERUM ALBUMIN)
2gfg BH2851
(Bacillus
halodurans)
3 / 3 VAL A  13
SER A  14
THR A  17
None
0.46A 4luhA-2gfgA:
undetectable
4luhA-2gfgA:
17.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EWJ_D_QELD503_1
(NMDA GLUTAMATE
RECEPTOR SUBUNIT
GLUTAMATE RECEPTOR
IONOTROPIC, NMDA 2B)
2gfg BH2851
(Bacillus
halodurans)
5 / 12 LEU A 135
ALA A 160
ILE A   7
THR A 170
GLU A 166
None
EDO  A 504 ( 4.3A)
None
None
None
1.33A 5ewjC-2gfgA:
undetectable
5ewjD-2gfgA:
undetectable
5ewjC-2gfgA:
19.02
5ewjD-2gfgA:
21.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L6E_A_SAMA601_0
(N6-ADENOSINE-METHYLT
RANSFERASE 70 KDA
SUBUNIT)
2gfg BH2851
(Bacillus
halodurans)
5 / 12 ILE A  22
LEU A 137
PHE A  32
GLY A  30
GLY A  28
None
None
EDO  A 502 (-3.9A)
None
None
1.02A 5l6eA-2gfgA:
undetectable
5l6eA-2gfgA:
19.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VW9_A_NCAA403_0
(FERREDOXIN--NADP
REDUCTASE)
2gfg BH2851
(Bacillus
halodurans)
5 / 8 THR A 155
GLY A 154
ALA A 160
GLY A 133
GLU A 131
EDO  A 504 (-4.3A)
EDO  A 504 (-3.2A)
EDO  A 504 ( 4.3A)
EDO  A 504 ( 4.4A)
None
1.22A 5vw9A-2gfgA:
undetectable
5vw9A-2gfgA:
19.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6BPL_B_PA1B605_1
(LIPID A EXPORT
ATP-BINDING/PERMEASE
PROTEIN MSBA)
2gfg BH2851
(Bacillus
halodurans)
3 / 3 ARG A 125
ARG A 184
ARG A  55
UNL  A 500 (-3.6A)
EDO  A 503 (-4.2A)
UNL  A 500 (-3.5A)
0.90A 6bplA-2gfgA:
undetectable
6bplB-2gfgA:
undetectable
6bplA-2gfgA:
18.72
6bplB-2gfgA:
18.72